Does RISDIPLAM Cause Product dose omission issue? 86 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Product dose omission issue have been filed in association with RISDIPLAM (EVRYSDI). This represents 2.4% of all adverse event reports for RISDIPLAM.
86
Reports of Product dose omission issue with RISDIPLAM
2.4%
of all RISDIPLAM reports
1
Deaths
16
Hospitalizations
How Dangerous Is Product dose omission issue From RISDIPLAM?
Of the 86 reports, 1 (1.2%) resulted in death, 16 (18.6%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISDIPLAM. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does RISDIPLAM Cause?
No adverse event (324)
Diarrhoea (280)
Asthenia (209)
Pneumonia (182)
Death (165)
Pyrexia (152)
Fatigue (145)
Muscular weakness (125)
Vomiting (121)
Drug ineffective (115)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which RISDIPLAM Alternatives Have Lower Product dose omission issue Risk?
RISDIPLAM vs RISEDRONATE
RISDIPLAM vs RISEDRONIC ACID
RISDIPLAM vs RISPERDAL
RISDIPLAM vs RISPERDAL CONSTA
RISDIPLAM vs RISPERIDONE